Roivant Sciences (ROIV) Fundamental Analysis: Revenue, Earnings & Valuation

2.18 / 10

Underperform

Roivant's fundamental score is weak (2.2/10). Key concerns include a low current assets turnover ratio (0.005) and sub-par Net profit / Total profit ratio (52.3%), which drag down performance. Conversely, strengths such as a high gross profit margin (96.9%) and solid Profit-MV (0.46) provide some cushion. The mixed factor profile leads to a defensive 'Underperform' rating, implying limited upside without clear catalysts.

Analysis Checks(5/10)

Revenue-MV

Value-0.26

Score1/3

Weight13.66%

1M Return5.20%

Inventory turnover ratio

Value111.00

Score3/3

Weight12.00%

1M Return5.26%

Gross profit margin (%)

Value96.86

Score2/3

Weight3.38%

1M Return1.47%

Profit-MV

Value0.46

Score2/3

Weight20.45%

1M Return7.79%

PB-ROE

Value1.09

Score0/3

Weight9.33%

1M Return3.56%

Current assets turnover ratio

Value0.01

Score0/3

Weight-3.74%

1M Return-1.88%

Fixed assets turnover ratio

Value2.12

Score2/3

Weight0.27%

1M Return0.12%

Asset-MV

Value-0.50

Score1/3

Weight24.78%

1M Return8.74%

Cash-MV

Value-0.07

Score2/3

Weight20.47%

1M Return7.73%

Net profit / Total profit (%)

Value52.34

Score0/3

Weight-0.60%

1M Return-0.30%

Is ROIV fundamentally strong?

ROIV scores 2.18/10 on fundamentals and holds a Premium valuation at present. Backed by its -6.74% ROE, -2824.78% net margin, -48.02 P/E ratio, 3.74 P/B ratio, and -108.94% earnings growth, these metrics solidify its Underperform investment rating.